The present study was undertaken to evaluate in-vivo hypolipidemic activity of a novel series of 2-methyl-2-(substituted phenyl isoxazol)phenoxyacetic acid derivatives by triton induced hyperlipidemia in rats. The newly synthesized compounds 5a, 5d and 5g showed significant decrease in the serum TCH, TG, LDL and VLDL along with an increase in serum HDL levels as compared to standard drug Fenofibrate
进行本研究以评价Triton诱导的高脂血症大鼠体内一系列新的2-甲基-2-(取代的苯基
异恶唑)苯氧基
乙酸衍
生物的体内降血脂活性。与标准药物
非诺贝特相比,新合成的化合物5a,5d和5g血清TCH,TG,LDL和VLDL显着降低,同时血清HDL
水平升高。与对照组相比,治疗组的动脉粥样硬化指数也显着降低,而保护活性的百分比提高。